LOOP Loop Industries (LOOP) Insider Trading, Ownership & Congress Trades
Pharma & Biotech · Chemicals & allied products · CIK 0001504678
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about LOOP
Insiders, 180 days
+$89.4K net bought
1 buyer
Loop Industries insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Loop Industries, Inc. insiders bought a net $89.4K of stock across 24 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Aug 18, 2026.
- The trade is 0.0% of the 3,355,094 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director GEYGAN JEFFREY RICHART bought about $700 of LOOP on Aug 19, 2026.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Jul 31, 2026.
- The trade is 0.7% of the 3,354,004 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director GEYGAN JEFFREY RICHART bought about $14.2K of LOOP on Aug 18, 2026.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Jul 30, 2026.
- The trade is 0.9% of the 3,331,904 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director GEYGAN JEFFREY RICHART bought about $22.6K of LOOP on Jul 31, 2026.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Jul 29, 2026.
- The trade is 1.9% of the 3,301,474 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director GEYGAN JEFFREY RICHART bought about $47.2K of LOOP on Jul 30, 2026.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 0.2% of the 3,238,579 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director GEYGAN JEFFREY RICHART bought about $4.8K of LOOP on Jul 29, 2026.24 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$89.4K over 180 days
+$89.4K over 90 days
more than 76% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-95.3% year over year
below 90% of Pharma & Biotech
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
2.5% of the float short (float per yahoo 2026-10-26) · 4.3 days to cover · settled 2026-09-30
below 69% of Pharma & Biotech
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch LOOP
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-84.5%12M
Insider buy13D/G stake
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns LOOP: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in LOOP
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
13D: intends to influence · 13G: passive
Global Value Investment Corporation
Activist 13D · 2026-04-10
5.85%
Jeffrey R. Geygan
Activist 13D · 2026-04-10
5.85%
James P. Geygan
Activist 13D · 2026-04-10
5.85%
Stacy A. Wilke
Activist 13D · 2026-04-10
5.85%
Kathleen M. Geygan
Activist 13D · 2026-04-10
5.85%
LOOP planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $89.4K bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
LOOP financials
Revenue growth
-95.3%
XBRL, annual
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$558.0K
four quarters, 2025-09-01 to 2026-08-31
Revenue, TTM LOOP
| FY Feb 2026 | $514.0K |
| FY Feb 2025 | $10.9M |
| FY Feb 2024 | $152.0K |
| FY Feb 2023 | $173.1K |
| FY Feb 2022 | $0 |
| Aug 2026 | $117.0K |
| May 2026 | $179.0K |
| Feb 2026 | $176.0K |
| Nov 2025 | $86.0K |
| Aug 2025 | $0 |
| May 2025 | $252.0K |
| Feb 2025 | $10.8M |
| Nov 2024 | $52.0K |
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Net margin, TTM LOOP
| FY Feb 2026 | n/a |
| FY Feb 2025 | -138.3% |
| FY Feb 2024 | n/a |
| FY Feb 2023 | n/a |
| FY Feb 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | -1,367% |
| Feb 2025 | +63.7% |
| Nov 2024 | n/a |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$6.9M
operating cash flow minus capex, 2025-09-01 to 2026-08-31
Free cash flow, TTM LOOP
| FY Feb 2026 | -$10.1M |
| FY Feb 2025 | -$2.1M |
| FY Feb 2024 | -$23.2M |
| FY Feb 2023 | -$35.0M |
| FY Feb 2022 | -$45.4M |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | $6.5M |
| Nov 2024 | -$1.9M |
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity LOOP
| FY Feb 2026 | n/a |
| FY Feb 2025 | 8.41x |
| FY Feb 2024 | 0.23x |
| FY Feb 2023 | 0.10x |
| FY Feb 2022 | 0.07x |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | 8.41x |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-2.40x
TTM operating cash flow over long-term 2026-08-31 plus current 2026-08-31
Cash flow to debt LOOP
| FY Feb 2026 | -3.33x |
| FY Feb 2025 | -0.69x |
| FY Feb 2024 | -5.44x |
| FY Feb 2023 | -10.57x |
| FY Feb 2022 | -12.01x |
| Aug 2026 | -2.40x |
| May 2026 | -2.74x |
| Feb 2026 | -3.33x |
| Nov 2025 | -0.29x |
| Aug 2025 | -0.30x |
| May 2025 | -0.40x |
| Feb 2025 | -0.69x |
| Nov 2024 | -3.74x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity LOOP
| FY Feb 2026 | n/a |
| FY Feb 2025 | -207.6% |
| FY Feb 2024 | -88.1% |
| FY Feb 2023 | -53.4% |
| FY Feb 2022 | -114.0% |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | -406.9% |
| Feb 2025 | -207.6% |
| Nov 2024 | -449.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-122.3%
TTM net income over average of 2025-08-31 and 2026-08-31
Return on assets LOOP
| FY Feb 2026 | -90.6% |
| FY Feb 2025 | -77.0% |
| FY Feb 2024 | -69.0% |
| FY Feb 2023 | -42.7% |
| FY Feb 2022 | -87.5% |
| Aug 2026 | -122.3% |
| May 2026 | -108.2% |
| Feb 2026 | -90.6% |
| Nov 2025 | -34.0% |
| Aug 2025 | -82.6% |
| May 2025 | -76.8% |
| Feb 2025 | -77.0% |
| Nov 2024 | -183.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital LOOP
| FY Feb 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Feb 2023 | n/a |
| FY Feb 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed LOOP
| FY Feb 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Feb 2023 | n/a |
| FY Feb 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing LOOP
| FY Feb 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Feb 2023 | n/a |
| FY Feb 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$14.2M
market value at close 2026-10-26 on 2026-10-15 shares, plus long-term 2026-08-31 plus current 2026-08-31, minus cash 2026-08-31
Enterprise value LOOP
| FY Feb 2026 | $63.5M |
| FY Feb 2025 | $53.4M |
| FY Feb 2024 | $145.6M |
| FY Feb 2023 | $97.1M |
| FY Feb 2022 | $288.2M |
| Aug 2026 | $25.4M |
| May 2026 | $69.2M |
| Feb 2026 | $63.5M |
| Nov 2025 | $52.6M |
| Aug 2025 | $66.9M |
| May 2025 | $55.5M |
| Feb 2025 | $53.4M |
| Nov 2024 | $73.3M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-56.5%
TTM free cash flow over market value at close 2026-10-26
FCF yield LOOP
| FY Feb 2026 | -16.1% |
| FY Feb 2025 | -3.3% |
| FY Feb 2024 | -15.6% |
| FY Feb 2023 | -28.3% |
| FY Feb 2022 | -13.8% |
| Aug 2026 | -29.6% |
| May 2026 | -12.3% |
| Feb 2026 | -16.1% |
| Nov 2025 | -1.6% |
| Aug 2025 | -1.3% |
| May 2025 | -2.1% |
| Feb 2025 | -3.3% |
| Nov 2024 | -24.2% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing LOOP
| FY Feb 2026 | n/a |
| FY Feb 2025 | n/a |
| FY Feb 2024 | n/a |
| FY Feb 2023 | n/a |
| FY Feb 2022 | n/a |
| Aug 2026 | n/a |
| May 2026 | n/a |
| Feb 2026 | n/a |
| Nov 2025 | n/a |
| Aug 2025 | n/a |
| May 2025 | n/a |
| Feb 2025 | n/a |
| Nov 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-02 | 2025-02 | 2024-09 | 2024-02 | |
|---|---|---|---|---|
| Revenue | $514.0K | $10.9M | n/a | $153.0K |
| Net income | -$12.3M | -$15.1M | n/a | -$21.1M |
| EPS (diluted) | n/a | -0.32 | n/a | -0.44 |
| Operating cash flow | -$10.1M | -$2.1M | n/a | -$18.0M |
| Cash | $2.4M | $13.0M | $7.0M | $7.0M |
| Long-term debt | $2.4M | $2.8M | n/a | $3.2M |
SEC XBRL, fiscal years, as known on 2026-10-28
LOOP Stock Sonar score 4/7 axes
Find similar shapesCompareLOOP ranks highest on risk and compliance (74th percentile) and insider conviction (66th), and lowest on growth (10th), among Pharma & Biotech peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
LOOP filings, in plain words
Are Loop Industries insiders buying or selling LOOP?
In the 180 days to 2026-10-28, Loop Industries insiders were net buyers, a net $89.4K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-28, Loop Industries insiders were net buyers of LOOP, a net $89.4K across purchases and sales reported on Form 4 by 1 buyer. The latest 5% ownership filing is a 13D by Global Value Investment Corporation, filed 2026-04-10, for 5.8% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
